https://nl.marketscreener.com/koers/aandeel/ALPHAMAB-ONCOLOGY-103501724/nieuws/Alphamab-Oncology-en-CSPC-Pharmaceutical-Group-Co-ontvangen-gezamenlijk-Breakthrough-Therapy-Design-45267496/?utm_source=telegram&utm_medium=social&utm_campaign=share